SELL and systemic lupus erythematosus: NKT-like cells from SLE patients expressed higher CD11b (28.7 ± 1.9% versus 21.0 ± 2.7%, p = 0.043) but comparable CD54 (8.5 ± 1.2% versus 13.2 ± 2.5%, p = 0.075) and CD62L (14565 ± 1392 versus 16676 ± 1630 [MFI], p = 0.317) compared to controls.